Institution
Hospital de Santa Cruz
PThealthcare
Recent research
- Health & Medicine
António Miguel Ferreira, MD, Luís Raposo, MD, PhD, Sérgio Baptista, MD, PhD; When the yardstick is the variable: the fractional flow reserve threshold as a
- Health & Medicine
BACKGROUND: Evolocumab, a PCSK9 (proprotein convertase subtilisin–kexin type 9) inhibitor, significantly reduced the risk of cardiovascular events in patients without previous myocardial infarction or stroke in the VESALIUS-CV trial (Effect of Evolocumab in Patients at High Cardi...